Long-term DHEA replacement in primary adrenal insufficiency: A randomized, controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 2, 2008, Pages 400-409

  Gurnell, Eleanor M ^b   Hunt, Penelope J ^d   Curran, Suzanne E ^b   Conway, Catherine L ^d   Pullenayegum, Eleanor M ^a   Huppert, Felicia A ^c   Compston, Juliet E ^b   Herbert, Joseph ^a   Chatterjee, V Krishna K ^b,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CHRISTCHURCH HOSPITAL   (New Zealand)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PRASTERONE; TESTOSTERONE;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SEXUAL FUNCTION; WELLBEING;

EID: 39049137056     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1134     Document Type: Article

References (56)

1. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
2. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H 1992 Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75:1002-1004
3. Barrett-Connor E, Khaw KT, Yen SSC 1986 A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med 315:1519-1524
4. Ebeling P, Kiovisto VA 1994 Physiological importance of dehydroepiandrosterone. Lancet 343:1479-1481
5. Sambrook P, Birmingham J, Champion D, Kelly P, Kempler S, Freund J, Eisman J 1992 Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens. J Rheumatol 19:357-361
6. Morales AJ, Nolan JJ, Nelson JC, Yen SSC 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
7. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SSC 1998 The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 49:421-432
8. Diamond P, Cusan L, Gomez J-L, Belanger A, Fabrie F 1996 Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150:S43-S50
9. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B 1997 Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505
10. Robel P, Bourreau E, Corpechot C, Dang DC, Halberg F, Clarke C, Haug M, Schlegel ML, Synguelakis M, Vourch C, Baulieu EE 1987 Neuro-steroids: 3β-hydroxy-Δ5-derivatives in rat and monkey brain. J Steroid Biochem 27:649-655
11. Robel P, Baulieu EE 1995 Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann NY Acad Sci 774:82-110
12. Li H, Klein G, Sun P, Buchan AM 2001 Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia. Brain Res 888:263-266
13. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J 1998 Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852-1857
14. Flood JF, Smith GE, Roberts E 1988 Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447:269-278
15. Karishma KK, Herbert J 2002 Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16:445-453
16. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W 1994 Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131:99-104
17. Browne ES, Wright BE, Porter JR, Svec F 1992 Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci 303:366-371
18. Maurer M, Trajanoski Z, Frey G, Hiroi N, Galon J, Willenberg HS, Gold PW, Chrousos GP, Scherbaum WA, Bornstein SR 2001 Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. Horm Metab Res 33:691-695
19. Baker SJK, Hunt PJ, Wass JAH 1997 Assessing the potential for finetuning the management of Addison's disease/steroid replacement therapy 188th Society for Endocrinology (UK) meeting, London. J Endocrinol Abstract Suppl 155:P2
20. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK 2000 Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650-4656
21. Lovas K, Loge JH, Husebye ES 2002 Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56:581-588
22. Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G 1997 Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 82:2578-2585
23. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
24. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA 2002 Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046-2052
25. Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BG, Myking OL, Kampe O, Husebye ES 2003 Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112-1118
26. Arlt W, Allolio B 2003 DHEA replacement in adrenal insufficiency. J Clin Endocrinol Metab 88:4001; author reply 4001-4002
27. Maehlen J, Torvik A 1990 Necrosis of granule cells of hippocampus in adrenocortical failure. Acta Neuropathol (Berl) 80:85-87
28. Eichenbaum H 1997 How does the brain organize memories? Science 277:330-332
29. O'Keefe J, Nadel L, Keightley S, Kill D 1975 Fornix lesions selectively abolish place learning in the rat. Exp Neurol 48:152-166
30. Owen AM, Morris RG, Sahakian BJ, Polkey CE, Robbins TW 1996 Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Brain 119(Pt 5):1597-1615
31. Zagar R, Arbit J, Stuckey M, Wengel WW 1984 Developmental analysis of the Wechsler Memory Scale. J Clin Psychol 40:1466-1473
32. Delis DC, Freeland J, Kramer JH, Kaplan E 1988 Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol 56:123-130
33. van Niekerk JK, Nielsen TA, Pasu S, Shore S, Huppert FA 2004 The development of new tests of source memory and a new approach to the testing of equivalence of parallel versions. Aging Neuropsychol Cognition 11:416-427
34. Nelson HE 1982 National Adult Reading Test (NART): test manual. Windsor, Berkshire, UK: NFER-Nelson
35. Keller SD, Ware Jr JE, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S, Leplege A, Sullivan M, Gandek B 1998 Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51:1179-1188
36. Jenkinson C, Stewart-Brown S, Petersen S, Paice C 1999 Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 53:46-50
37. Smets EM, Garssen B, Cull A, de Haes JC 1996 Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73:241-245
38. Goldberg DP 1978 Manual of the General Health Questionnaire. Windsor, UK: NFER Publishing
39. Huppert FA, Walters DE, Day N, Elliott BJ 1989 The factor structure of the General Health Questionnaire (GHQ-30): a reliability study on 6317 community residents. Br J Psychiatry 155:178-185
40. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F 2000 Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 97:4279-4284
41. Kligman AM, Miller DL, McGinley KJ 1986 Sebutape: a device for visualizing and measuring human sebaceous secretion. J Soc Cosmet Chem 37:369-374
42. Sourla A, Flamand M, Belanger A, Labrie F 1998 Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol 66:137-149
43. Miller KK, Biller BM, Hier J, Arena E, Klibanski A 2002 Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab 87:2770-2776
44. Osmanagaoglu MA, Okumus B, Osmanagaoglu T, Bozkaya H 2004 The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J Womens Health (Larchmt) 13:993-999
45. Tok EC, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S 2004 The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas 48:235-242
46. Hampson G, Bhargava N, Cheung J, Vaja S, Seed PT, Fogelman I 2002 Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. Metabolism 51:1458-1462
47. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton 3rd LJ, Smith GE, Khosla S, Jensen MD 2006 DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659
48. Libe R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B 2004 Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 27:736-741
49. Villareal DT, Holloszy JO 2004 Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243-2248
50. Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jorgensen JO 2004 Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GHsecretion and IGF-related parameters. Clin Endocrinol (Oxf) 60:461-469
51. van Niekerk JK, Huppert FA, Herbert J 2001 Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 26:591-612
52. Huppert FA, Van Niekerk JK, Herbert J 2000 Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being. Cochrane Database Syst Rev CD000304
53. Fonda SJ, Bertrand R, O'Donnell A, Longcope C, McKinlay JB 2005 Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci 60:385-390
54. van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW 2005 Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90:3295-3303
55. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA 2000 Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682-688
56. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S 2005 Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90:5226-5233